Infant Bacterial Therapeutics AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.08.18	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2018 (GlobeNewswire)
26.06.18	IBT plans to start its phase 3 study in the second half of 2018 and contracts CRO (GlobeNewswire)
15.05.18	Annual General Meeting of Infant Bacterial Therapeutics AB (GlobeNewswire)
15.05.18	Update: Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018 (GlobeNewswire)
15.05.18	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018 (GlobeNewswire)
09.05.18	Infant Bacterial Therapeutics AB Nomination Committee modifies its proposal to the Board of Directors (GlobeNewswire)
16.04.18	Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) (GlobeNewswire)
12.04.18	Infant Bacterial Therapeutics publishes Annual Report for 2017 (GlobeNewswire)
28.02.18	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - December 31, 2017 (GlobeNewswire)
02.02.18	Outcome of Infant Bacterial Therapeutics' rights issue (GlobeNewswire)
10.01.18	Prospectus relating to Infant Bacterial Therapeutics' rights issue published (GlobeNewswire)
08.01.18	Extraordinary general meeting in Infant Bacterial Therapeutics (GlobeNewswire)
24.11.17	Infant Bacterial Therapeutics announces capital raise of approximately SEK 545 million in total (GlobeNewswire)
23.11.17	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - September 29, 2017 (GlobeNewswire)
08.11.17	Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2018 (GlobeNewswire)
28.09.17	European Medicines Agency adopts a positive opinion on the Paediatric Investigation Plan for IBT's lead product (GlobeNewswire)
11.09.17	Infant Bacterial Therapeutics announces that top line data demonstrate similar safety and tolerability profile in the active and placebo groups. (GlobeNewswire)
08.09.17	Information from Infant Bacterial Therapeutics Capital Markets Day 2017 (GlobeNewswire)
28.08.17	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - June 30, 2017 (GlobeNewswire)
14.12.16	IBT adds new indication for Gastroschisis-Related Intestinal Dysfunction (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Nestle	74.24	0.27 %	K V
Swisscom	507.50	0.20 %	K V
CieFinRichemont	138.45	-0.04 %	K V
Swiss Re	131.10	-0.27 %	K V
Sika	217.40	-0.28 %	K V
ABB	48.63	-1.26 %	K V
UBS Group	29.30	-1.61 %	K V
Lonza Grp	544.40	-1.73 %	K V
Part Grp Hldg	1’281.00	-2.66 %	K V
Holcim	84.32	-3.83 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Infant Bacterial Therapeutics AB (B)

Aktien Top/Flop

Meistgelesene Nachrichten